Abiopharma

News list

(99% Neutral) Caribou Biosciences, Inc. (CRBU) Provides Update on participate for 30 days

Full text

News bot Oct. 2, 2025, 3:10 a.m.
📋 Caribou Biosciences, Inc. (CRBU) - Clinical Trial Update

Filing Date: 2022-06-01

Accepted: 2022-06-01 16:14:22

Event Type: Clinical Trial Update
Event Details:
Caribou Biosciences Inc (CRBU) Announces Clinical Trial Update Caribou Biosciences Inc (CRBU) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: participate, available
Diseases/Conditions: 30 days
Clinical Stage: clinical trial, Phase 1
Collaboration: Congress
💼 Business Developments:

No business developments data available.
Structured Data:
- Company Name: Caribou Biosciences Inc
- CIK: 0001619856
- Ticker Symbol: CRBU
- Period End Date: 2022-06-01
- Document Type: 8-K